[Drug therapy of mental disorders and the eye (review)].
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D002090:Butyrophenones; D004121:Dimethyl Sulfoxide / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D001523:Mental Disorders / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010640:Phenothiazines; D011619:Psychotropic Drugs / Q000009:adverse effects*; D013892:Thioxanthenes / Q000009:adverse effects
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D002090:Butyrophenones; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D011619:Psychotropic Drugs; D013892:Thioxanthenes; D008094:Lithium; D004121:Dimethyl Sulfoxide
Lekarstvennaia terapiia psikhicheskikh zabolevaniĭ i organ zreniia (obzor).